Moelis & Co (MC) director Mirrer receives dividend-equivalent RSU grants

Rhea-AI Filing Summary

Moelis & Company reported director equity awards tied to prior grants. Director Louise Mirrer filed a Form 4 for Restricted Stock Units (RSUs) in Moelis & Co Class A Common Stock as of 12/04/2025.

The filing shows several lines of 2024 and 2025 Annual RSUs that were acquired as dividend equivalents on her existing Annual RSU awards from September 2024, May 2025, and July 2025. Each RSU represents the right to receive one share of Class A Common Stock, and the dividend-equivalent RSUs will vest on the same schedule as the underlying Annual RSUs.

The form is filed for one reporting person, in her capacity as a director, and is signed by an attorney-in-fact on her behalf.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mirrer Louise

(Last) (First) (Middle)

399 PARK AVE

(Street)

NEW YORK NY 10022

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Moelis & Co [ MC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
2024 Annual Restricted Stock Units	12/04/2025		A		12.26	A	(1)(2)	1,265.56	D
2024 Annual Restricted Stock Units	12/04/2025		A		0.38	A	(1)(3)	39.14	D
2025 Annual Restricted Stock Units	12/04/2025		A		16.58	A	(1)(4)	1,711.63	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Each Restricted Stock Unit (RSU) represents the right to receive one share of Class A Common Stock.

2. 2024 Annual RSUs were issued as dividend equivalents on holder's underlying Annual RSUs issued on September 24, 2024. The dividend equivalent Annual RSUs will vest concurrently with the vesting of the underlying Annual RSUs.

3. 2024 Annual RSUs were issued as dividend equivalents on holder's underlying Annual RSUs issued on May 1, 2025. The dividend equivalent Annual RSUs will vest concurrently with the vesting of the underlying Annual RSUs.

4. 2025 Annual RSUs were issued as dividend equivalents on holder's underlying Annual RSUs issued on July 1, 2025. The dividend equivalent Annual RSUs will vest concurrently with the vesting of the underlying Annual RSUs.

	/s/ Osamu Watanabe as attorney-in-fact for Louise Mirrer	12/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Moelis & Co (MC) disclose in this Form 4 filing?

Moelis & Co disclosed that director Louise Mirrer acquired Restricted Stock Units (RSUs) in Class A Common Stock on 12/04/2025, reported as equity awards rather than open-market purchases or sales.

What type of securities did Louise Mirrer receive from Moelis & Co (MC)?

She received Restricted Stock Units (RSUs), and each RSU represents the right to receive one share of Moelis & Co Class A Common Stock, as stated in the explanation of responses.

Why are the 2024 and 2025 Annual RSUs mentioned in the Moelis & Co (MC) Form 4?

The Form 4 explains that the 2024 and 2025 Annual RSUs were issued as dividend equivalents on her underlying Annual RSUs granted on September 24, 2024, May 1, 2025, and July 1, 2025.

How do the dividend-equivalent RSUs for Moelis & Co (MC) vest?

The dividend-equivalent Annual RSUs will vest concurrently with the vesting of the underlying Annual RSUs referenced for each of the 2024 and 2025 awards.

What is Louise Mirrer’s relationship to Moelis & Co (MC) in this filing?

In this Form 4, the reporting person is identified as a director of Moelis & Co, and the form is filed by one reporting person.

Who signed the Moelis & Co (MC) Form 4 for these RSU awards?

The Form 4 is signed by /s/ Osamu Watanabe as attorney-in-fact for Louise Mirrer, with a signature date of 12/05/2025.